Physician profile
Shani Stein
NPI 1023207263
$518.15
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $132 · 2022: $108 · 2023: $207 · 2024: $71.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $278.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $131.96 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $99.64 | 2023-2024 | Austedo Xr, Uzedy |
| Neurocrine Biosciences, INC. | $68.10 | 2022-2023 | Ingrezza |
| Lundbeck LLC | $48.88 | 2023-2024 | Abilify Asimtufii, Abilify Maintena |
| Janssen Pharmaceuticals, INC | $46.93 | 2022-2023 | Invega Sustenna, Invega Trinza |
| Alkermes, INC. | $45.32 | 2022-2023 | Aristada, Lybalvi |
| Axsome Therapeutics, INC. | $28.74 | 2023 | Auvelity |
| Gilead Sciences, INC. | $22.27 | 2023 | Epclusa |
| Vanda Pharmaceuticals INC. | $14.21 | 2023 | Hetlioz, Fanapt |
| Almatica Pharma LLC | $12.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shani Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.